In clinical trials the treatment — which involves extracting individual patients» immune T - cells, modifying them to seek out tell -
tale biological markers associated with blood cancers like aggressive lymphoma, and then pumping those modified killer cells back into the body — has shown major
promise, in some cases eliminating all
signs of the cancer in patients six months after treatment.
Additionally, there are no tell -
tale signs of usual scams such as paid actors enacting the role
of traders and neither are there any exaggerated
promises of gaining quick wealth.